Cargando…

A novel oncogenic enhancer of estrogen receptor-positive breast cancer

Estrogen receptor-positive (ER(+)) breast cancer accounts for the majority of breast cancers diagnosed, and nearly 20% of patients do not respond to endocrine therapy. The pathogenesis of ER(+) breast cancer has not been well elucidated. The enhancer is a cis-regulatory element that promotes gene tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bao, Chunjie, Duan, Jialun, Xie, Ying, Liu, Yixuan, Li, Peishan, Li, Jianwei, Zhao, Huihui, Guo, Haitao, Men, Yanchen, Ren, Yuxin, Xu, Jiarui, Wang, Guiling, Lu, Wanliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463563/ https://www.ncbi.nlm.nih.gov/pubmed/36159594 http://dx.doi.org/10.1016/j.omtn.2022.08.029

Ejemplares similares

Engineered targeting tLyp-1 exosomes as gene therapy vectors for efficient delivery of siRNA into lung cancer cells
por: Bai, Jing, et al.
Publicado: (2020)

Artesunate Suppresses the Proliferation and Development of Estrogen Receptor-α-Positive Endometrial Cancer in HAND2-Dependent Pathway
por: Yin, Xianghua, et al.
Publicado: (2021)

Study of the Sensing Kinetics of G Protein-Coupled Estrogen Receptor Sensors for Common Estrogens and Estrogen Analogs
por: Lu, Dingqiang, et al.
Publicado: (2023)

Water Extract of Rhizoma Drynaria Selectively Exerts Estrogenic Activities in Ovariectomized Rats and Estrogen Receptor-Positive Cells
por: Zhou, Liping, et al.
Publicado: (2022)

Adjuvant endocrine therapy in patients with estrogen receptor-low positive breast cancer: A prospective cohort study
por: Xie, Yuxin, et al.
Publicado: (2022)

AGR3 promotes estrogen receptor-positive breast cancer cell proliferation in an estrogen-dependent manner
por: Jian, Lei, et al.
Publicado: (2020)

Oncogenic MORC2 in cancer development and beyond
por: Zhang, Shan, et al.
Publicado: (2023)

Genes Dysregulated to Different Extent or Oppositely in Estrogen Receptor-Positive and Estrogen Receptor-Negative Breast Cancers
por: Zhou, Xianxiao, et al.
Publicado: (2013)

The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer
por: Golden, Emily, et al.
Publicado: (2021)

Expression of Oncogenes during Rat Chemical Hepatotumorigenesis Promoted by Estrogen
por: Himeno, Yasuo, et al.
Publicado: (1989)

Estrogen Receptors and Estrogen-Induced Uterine Vasodilation in Pregnancy
por: Bai, Jin, et al.
Publicado: (2020)

The BCL9-2 proto-oncogene governs estrogen receptor alpha expression in breast tumorigenesis
por: Zatula, Nathalie, et al.
Publicado: (2014)

Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells
por: Shen, Minqian, et al.
Publicado: (2016)

The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer
por: Allred, D Craig, et al.
Publicado: (2004)

Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
por: Datta, Jharna, et al.
Publicado: (2022)

Natural product-derived icaritin exerts anti-glioblastoma effects by positively modulating estrogen receptor β
por: Li, Xiaowen, et al.
Publicado: (2020)

Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers
por: Raj, Ganesh V, et al.
Publicado: (2017)

Alternative splicing of estrogen receptor alpha in hepatocellular carcinoma
por: Zhang, Jian, et al.
Publicado: (2016)

Role of Estrogen Receptor-Positive/Negative Ratios in Regulating Breast Cancer
por: Li, Yanchu, et al.
Publicado: (2022)

Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
por: Gao, Pin, et al.
Publicado: (2018)

Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers
por: Chiu, Jen-Hwey, et al.
Publicado: (2017)

Estrogen receptor α is involved in the regulation of ITGA8 methylation in estrogen receptor-positive breast cancer
por: Wu, Jingxun, et al.
Publicado: (2020)

Benzoquinone from Fusarium pigment inhibits the proliferation of estrogen receptor-positive MCF-7 cells through the NF-κB pathway via estrogen receptor signaling
por: Zheng, Lixiang, et al.
Publicado: (2017)

Estrogen, Estrogen Receptor and Lung Cancer
por: Hsu, Li-Han, et al.
Publicado: (2017)

Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer
por: Jia, Xiaoqing, et al.
Publicado: (2015)

Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer
por: Lee, Kiwon, et al.
Publicado: (2008)

Survival Benefit of Tamoxifen in Estrogen Receptor-Negative and Progesterone Receptor-Positive Low Grade Breast Cancer Patients
por: Yang, Li-Heng, et al.
Publicado: (2012)

Schisandrol A Exhibits Estrogenic Activity via Estrogen Receptor α-Dependent Signaling Pathway in Estrogen Receptor-Positive Breast Cancer Cells
por: Lee, Dahae, et al.
Publicado: (2021)

The impact of endogenous estrogen exposures on the characteristics and outcomes of estrogen receptor positive, early breast cancer
por: Korzets, Yasmin, et al.
Publicado: (2021)

Expression of Androgen Receptor in Estrogen Receptor–positive Breast Cancer
por: Agrawal, Anil, et al.
Publicado: (2016)

Mouse models of estrogen receptor-positive breast cancer
por: Mohibi, Shakur, et al.
Publicado: (2011)

Positive Regulation of Estrogen Receptor Alpha in Breast Tumorigenesis
por: Porras, Lucas, et al.
Publicado: (2021)

Estrogen receptor-β: why may it influence clinical outcome in estrogen receptor-α positive breast cancer?
por: Shupnik, Margaret A
Publicado: (2007)

Estrogen Receptor Bio-Activities Determine Clinical Endocrine Treatment Options in Estrogen Receptor-Positive Breast Cancer
por: Xia, Song, et al.
Publicado: (2022)

Estrogen Receptor- And Progesterone Receptor-Positive Thresholds in Predicting the Recurrence of Early Low-Risk Endometrial Cancer
por: Li, Ning, et al.
Publicado: (2022)

MiR-203 inhibits estrogen-induced viability, migration and invasion of estrogen receptor α-positive breast cancer cells
por: Lin, Jun, et al.
Publicado: (2021)

Local and Systemic Delivery of the BimS Gene Nano-Complex for Efficient Oral Squamous Cell Carcinoma Therapy
por: Ma, Pingchuan, et al.
Publicado: (2022)

In vitro and in vivo Evaluation of a Novel Estrogen-Targeted PEGylated Oxaliplatin Liposome for Gastric Cancer
por: Sun, Yuxin, et al.
Publicado: (2021)

Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer
por: Switzer, Christopher H, et al.
Publicado: (2012)

Estrogen independent gene expression defines clinically relevant subgroups of estrogen receptor positive breast cancer
por: Hallett, Robin M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pj149b2rpbsjgavlgr6ftmvemb